Category Specific RSS

baby formula

Bubs Australia rebounds in China after CEO fiasco, sees USA growth

Baby formula company Bubs Australia (ASX: BUB) has all but closed the chapter on its financial and legal troubles that…

1 year ago

Bubs goes full steam ahead with US FDA trials in rising market for infant formula

Baby formula and food company Bubs Australia (ASX: BUB) spent a large part of FY23 undertaking reputation management as its…

2 years ago

Bubs Australia founder and CEO forced out for alleged failure to comply with board directions

Just a month after Bubs Australia (ASX: BUB) announced that executive chairman Dennis Lin would be removed from the business,…

2 years ago

FDA deferral the latest of woes for A2 Milk as class action pasteurises

The FDA has deferred further consideration of one of Australia’s top dairy producers A2 Milk’s (ASX: A2M) request to import…

3 years ago

Bubs expands further in US with new distribution agreements for second formula import

It’s hard to believe that in 2022 food security in America would be an issue, but for thousands of parents,…

3 years ago

Aussie infant formula Bubs is lending a hand in the American formula crisis with tons of product flown in

It’s the most talked about stock in the retail investor community right now, and having climbed 61.84% in the past…

3 years ago